Sanofi (SNY) Operating Leases (2019 - 2025)

Sanofi (SNY) has 7 years of Operating Leases data on file, last reported at $2.0 billion in Q4 2025.

• Quarterly Operating Leases rose 15.16% year-over-year to $2.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 billion (up 15.16% YoY) and the FY2025 annual result came in at $2.0 billion, up 15.16% from the prior year.
• Operating Leases rose to $2.0 billion in Q4 2025 per SNY's latest filing, from $1.7 billion in the prior quarter.
• The five-year high for Operating Leases was $2.2 billion in Q4 2023, with the low at $1.5 billion in Q2 2021.
• Average Operating Leases over 5 years is $1.9 billion, with a median of $2.0 billion recorded in 2022.
• Year-over-year, Operating Leases jumped 43.39% in 2021 and slipped 19.52% in 2024.
• Sanofi's Operating Leases stood at $2.1 billion in 2021, then fell by 7.66% to $1.9 billion in 2022, then grew by 12.44% to $2.2 billion in 2023, then decreased by 19.52% to $1.8 billion in 2024, then gained by 15.16% to $2.0 billion in 2025.
• Business Quant data shows SNY's Operating Leases at $2.0 billion in Q4 2025, $1.7 billion in Q2 2025, and $1.8 billion in Q4 2024.